[go: up one dir, main page]

DK3281636T3 - Fremgangsmåde til fremstilling og oprensning af rekombinant lysosomal alfa-mannosidase - Google Patents

Fremgangsmåde til fremstilling og oprensning af rekombinant lysosomal alfa-mannosidase Download PDF

Info

Publication number
DK3281636T3
DK3281636T3 DK17192938.3T DK17192938T DK3281636T3 DK 3281636 T3 DK3281636 T3 DK 3281636T3 DK 17192938 T DK17192938 T DK 17192938T DK 3281636 T3 DK3281636 T3 DK 3281636T3
Authority
DK
Denmark
Prior art keywords
purification
procedure
preparation
recombinant lysosomal
mannosidase
Prior art date
Application number
DK17192938.3T
Other languages
English (en)
Inventor
Jens Fogh
Cecilia Weigelt
Helena Reuterwall
Stefan Nilsson
Claes Andersson
Pia Hydén
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Application granted granted Critical
Publication of DK3281636T3 publication Critical patent/DK3281636T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477Hemicellulases not provided in a preceding group
    • C12N9/2488Mannanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01024Alpha-mannosidase (3.2.1.24)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK17192938.3T 2010-02-24 2011-02-23 Fremgangsmåde til fremstilling og oprensning af rekombinant lysosomal alfa-mannosidase DK3281636T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30758710P 2010-02-24 2010-02-24
DKPA201070067 2010-02-24
EP11705806.5A EP2538968B1 (en) 2010-02-24 2011-02-23 Process for production and purification of recombinant lysosomal alpha-mannosidase

Publications (1)

Publication Number Publication Date
DK3281636T3 true DK3281636T3 (da) 2020-09-21

Family

ID=43920349

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11705806.5T DK2538968T3 (da) 2010-02-24 2011-02-23 Fremgangsmåde til fremstilling og oprensning af rekombinant lysosomal alfa-mannosidase
DK17192938.3T DK3281636T3 (da) 2010-02-24 2011-02-23 Fremgangsmåde til fremstilling og oprensning af rekombinant lysosomal alfa-mannosidase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK11705806.5T DK2538968T3 (da) 2010-02-24 2011-02-23 Fremgangsmåde til fremstilling og oprensning af rekombinant lysosomal alfa-mannosidase

Country Status (25)

Country Link
US (3) US8974780B2 (da)
EP (2) EP3281636B1 (da)
JP (1) JP6021647B2 (da)
KR (1) KR101856260B1 (da)
CN (1) CN102834111B (da)
AU (1) AU2011220163B2 (da)
BR (1) BR112012020934B1 (da)
CA (1) CA2790786C (da)
CY (2) CY1123438T1 (da)
DK (2) DK2538968T3 (da)
EA (1) EA022220B1 (da)
ES (1) ES2652330T3 (da)
FR (1) FR18C1038I2 (da)
HK (1) HK1179869A1 (da)
HR (1) HRP20171736T1 (da)
HU (2) HUE037943T2 (da)
LT (2) LT2538968T (da)
NL (1) NL300948I2 (da)
NO (2) NO2538968T3 (da)
NZ (1) NZ601790A (da)
PL (2) PL2538968T3 (da)
PT (1) PT2538968T (da)
RS (1) RS60983B1 (da)
SI (2) SI3281636T1 (da)
WO (1) WO2011103877A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9169331B2 (en) * 2012-12-21 2015-10-27 Dionex Corporation Separation of glycans by mixed-mode liquid chromatography
US9310344B2 (en) 2013-06-14 2016-04-12 Dionex Corporation HILIC/anion-exchange/cation-exchange multimodal media
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
MX2018003298A (es) * 2015-09-22 2018-06-20 Pfizer Metodo para preparar una formulacion de proteinas terapeuticas y formulacion de anticuerpos producida por tal metodo.
CN111100196B (zh) * 2019-11-08 2021-07-13 上海交通大学 一种生物活性多肽qilsvpgwtysr及其制备方法和应用
WO2024233992A2 (en) * 2023-05-11 2024-11-14 Trophogen, Inc. Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63327A (en) * 1981-07-16 1985-11-29 Yeda Res & Dev Production of interferon beta1 and alpha-phage recombinants for its production in host bacteria
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
JP4320870B2 (ja) 1999-10-18 2009-08-26 住友化学株式会社 (+)−トランス第一菊酸の製造方法
GB0007651D0 (en) * 2000-03-29 2000-05-17 Ascorbex Ltd Gene sequence
US7138262B1 (en) * 2000-08-18 2006-11-21 Shire Human Genetic Therapies, Inc. High mannose proteins and methods of making high mannose proteins
AU2002317701A1 (en) * 2001-06-07 2002-12-16 Hemebiotech A/S Production of recombinant human lysosomal alpha-mannosidase
JP4742191B2 (ja) * 2001-06-14 2011-08-10 独立行政法人産業技術総合研究所 糖蛋白質およびその製造方法
US7507573B2 (en) * 2003-11-14 2009-03-24 Vib, Vzw Modification of protein glycosylation in methylotrophic yeast
EP1713904B1 (en) * 2004-01-30 2016-06-29 Shire Pharmaceuticals Ireland Limited Production and purification of recombinant arylsulfatase a
US20080014188A1 (en) * 2004-02-06 2008-01-17 Zankel Todd C Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof
DK1740204T3 (da) 2004-04-01 2018-05-22 Chiesi Farm Spa Medicinsk anvendelse af alfa-mannosidase
CN105233276A (zh) * 2006-04-04 2016-01-13 希尔制药爱尔兰有限责任公司 用于浓缩多肽的方法
CN101410408A (zh) * 2006-04-04 2009-04-15 希尔制药爱尔兰有限责任公司 用于浓缩多肽的方法
PL2167526T3 (pl) * 2007-07-11 2011-09-30 Novo Nordisk As Oczyszczanie czynnika VIII za pomocą żywicy o mieszanej funkcji lub wielofunkcyjnej

Also Published As

Publication number Publication date
PT2538968T (pt) 2018-01-23
WO2011103877A1 (en) 2011-09-01
FR18C1038I2 (fr) 2019-10-11
US8974780B2 (en) 2015-03-10
CA2790786A1 (en) 2011-09-01
KR20120128647A (ko) 2012-11-27
AU2011220163B2 (en) 2015-05-28
HRP20171736T1 (hr) 2018-01-26
RS60983B1 (sr) 2020-11-30
LT2538968T (lt) 2018-01-10
US20150306186A1 (en) 2015-10-29
EA022220B1 (ru) 2015-11-30
LTPA2018512I1 (lt) 2018-10-10
JP6021647B2 (ja) 2016-11-09
HK1179869A1 (en) 2013-10-11
US20120308549A1 (en) 2012-12-06
CN102834111A (zh) 2012-12-19
SI2538968T1 (en) 2018-04-30
JP2013520184A (ja) 2013-06-06
CY2021002I1 (el) 2021-05-05
CY1123438T1 (el) 2021-05-05
EP2538968A1 (en) 2013-01-02
NZ601790A (en) 2014-03-28
CA2790786C (en) 2019-09-24
BR112012020934A8 (pt) 2018-02-06
EP3281636A1 (en) 2018-02-14
ES2652330T3 (es) 2018-02-01
DK2538968T3 (da) 2017-12-11
US10159718B2 (en) 2018-12-25
HUE037943T2 (hu) 2018-09-28
AU2011220163A1 (en) 2012-08-30
SI3281636T1 (sl) 2020-11-30
PL3281636T3 (pl) 2021-03-08
EP2538968B1 (en) 2017-11-01
EA201270715A1 (ru) 2013-01-30
NL300948I2 (nl) 2019-02-27
HUS1800037I1 (hu) 2018-09-28
CN102834111B (zh) 2014-11-12
EP3281636B1 (en) 2020-08-05
US20180036387A1 (en) 2018-02-08
BR112012020934B1 (pt) 2021-07-13
FR18C1038I1 (da) 2018-11-02
PL2538968T3 (pl) 2018-04-30
NO2538968T3 (da) 2018-03-31
BR112012020934A2 (pt) 2017-02-21
LTC2538968I2 (lt) 2019-11-11
KR101856260B1 (ko) 2018-05-09
NO2018032I1 (no) 2018-09-14

Similar Documents

Publication Publication Date Title
DK3192520T3 (da) Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
DK2558105T3 (da) Bardoxolonmethyl til behandling af fedme
DK3494972T3 (da) Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion
DK3202460T3 (da) Arylmethoxy-isoindolinderivater og sammensætninger omfattende og fremgangsmåder til anvendelser af samme
PL3299380T3 (pl) Sposoby oczyszczania polipeptydów
DK2533801T3 (da) Bakterielle deoxyribonuklease-forbindelser og fremgangsmåder til biofilm opløsning og forebyggelse
ME03475B (me) Antiparazitske kompozicije dihidroazola
DK2475372T4 (da) Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse
DK2459715T3 (da) Fremgangsmåde til at oprense rekombinant adamts13 og andre proteiner og sammensætninger deraf
DK2417308T3 (da) Bygning og fremgangsmåde til opførelse af en bygning
DK2547771T3 (da) Fremstilling af proteiner og polypeptider
DK2688557T3 (da) Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
DK2462116T3 (da) Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser
DK2663864T3 (da) Fremgangsmåde til at vurdere immundiversitet og anvendelse af denne
DK3591046T3 (da) Amylasepolypeptide
DK2598457T3 (da) Vandig opslæmning af amorf silica og fremgangsmåde til fremstilling heraf
DK2598516T3 (da) Fremgangsmåde til proteinoprensning
DK2627656T3 (da) Fremgangsmåde til fremstilling af dihydropteridinon og intermediater deraf
DK2533761T3 (da) Fremgangsmåder og sammensætninger til fremstilling af aerosoler
DK2260873T3 (da) Pcylering af proteiner
DK3284820T3 (da) Fremgangsmåde til behandling af pyropheophytin-holdige sammensætninger
FR2945298B1 (fr) Pont temporaire perfectionne
DK2415349T3 (da) Fremgangsmåde til fremstilling af afsaltet mælk, og afsaltet mælk
DK2630113T3 (da) Glycidylestere af alfa, alfa-forgrenede neononansyrer, syntese og anvendelser
PT2504298T (pt) Preparação e purificação de iodoxanol